课题基金 / 基金详情

CLINICAL TRIAL: EXTRARENAL 1-ALPHA-HYDROXYLASE IN END-STAGE RENAL DISEASE

CLINICAL TRIAL: EXTRARENAL 1-ALPHA-HYDROXYLASE IN END-STAGE RENAL DISEASE
临床试验:肾外 1-α-羟化酶治疗终末期肾病
批准号:
7951220
负责人:
Jason Stubbs
金额:
$6.63万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2010-03-31

项目摘要

项目成果

Jason Stubbs的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 本研究的目的是确定膳食维生素D对需要透析的终末期肾功能衰竭患者白细胞功能的影响。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine the effects of dietary vitamin D on the fundtion of white blood cells in patients with end-stage kidney failure who are requiring dialysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Phosphaturia on Renal Osteopontin Production and PKD Progression
Impact of Phosphaturia on Renal Osteopontin Production and PKD Progression
Impact of Phosphaturia on Renal Osteopontin Production and PKD Progression
Impact of Phosphaturia on Renal Osteopontin Production and PKD Progression
海外基金